advertisement
E-mail Page
Print Format
Google - Traducir esta página a español.
Google - Traduza esta página ao português.
 

  Back to Ask the Diabetes Team Ask the Diabetes Team
Question:

From Phoenix, Arizona, USA:

I have a 13 year old son that was diagnosed Type 1 two years ago. A year ago, my 17 year old tested positive for ICA and insulin antibodies and does not have the protective gene (HLA?). My 9 year old son just tested positive for ICA after testing negative one year ago. We are working with the Diabetes Prevention Trial for further testing.

My questions are:

  • How much do all of these genetic markers mean?
  • What are my nondiabetic sons' chances of becoming diabetic?
  • My sister and her daughter are also Type 1 diabetics. Is this cluster unusual?

Answer:

The HLA and antibody markers that you asked about are all measures of the probability of developing insulin dependent Type 1 Diabetes, the kind that your 13 year old has. For just one antibody, these chances in preliminary studies are about 8% after 3 years, 15% at five years and about 20% at 10 years. The likelihood can be more precisely defined by measuring what is called first phase insulin release (i.e., serum insulin levels after a glucose load). With two antibodies, the respective figures are 30%, 40% and 70%. With all three antibodies present there is a 100% chance of clinical diabetes in 5 years.

Three studies are in progress at the moment. In Europe, there is a trial of nicotinamide to see if it will defer insulin dependence. In this country, for those with two or more antibodies,there is a trial of small doses of injected insulin and in the last month a third trial of 'vaccination' with oral insulin has begun. Another contemporary trial called DAISY is attempting to evaluate the environmental factors that trigger the conversion of genetic susceptibility to a damaging auto-immune process.

The objective of HLA typing is to establish risk tables for the various patterns (haplotypes). From these it will be possible to devise tests that have a maximum chance of detecting future diabetics before antibodies develop and at reasonable cost.

Plans are already underway for screening population samples thus selected, perhaps in the newborn, perhaps prekindergarten, with a view to actually preventing clinical diabetes rather than just deferring insulin dependence. Again, oral insulin may be used for 'vaccination' and perhaps also a fragment of the B chain of insulin (B9-23) that has shown promise in the NOD mouse when injected.

The high incidence of Type 1 diabetes in your family may be just statistical misfortune or it may be due to a unique HLA gene. In Norway, for example, the HLA type DRB1*0401 was reported to confer a fivefold increase risk of clinical diabetes.

A complex story; I hope this gives you a glimpse.

DO'B

Original posting 20 Nov 96

  
advertisement


 
Not Helpful  1 2 3 4 5  Very Helpful                  E-mail Article E-mail Page     Printer Friendly format Print Format    
  Home Return to Top

Last Updated: Tuesday April 06, 2010 15:08:51
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

US Flag This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.